Hurwitz H - Search Results

1

Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.

Ou FS, Ahn DH, Dixon JG, Grothey A, Lou Y, Kasi PM, Hubbard JM, Van Cutsem E, Saltz LB, Schmoll HJ, Goldberg RM, Venook AP, Hoff P, Douillard JY, Hecht JR, Hurwitz H, Punt CJA, Koopman M, Bokemeyer C, Fuchs CS, Diaz-Rubio E, Tebbutt NC, Cremolini C, Kabbinavar FF, Bekaii-Saab T, Chibaudel B, Yoshino T, Zalcberg J, Adams RA, de Gramont A, Shi Q. Ou FS, et al. Among authors: hurwitz h. Cancers (Basel). 2023 Aug 15;15(16):4117. doi: 10.3390/cancers15164117. Cancers (Basel). 2023. PMID: 37627145 Free PMC article.

2

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.

Kabbinavar F, Hurwitz HI, Fehrenbacher L, Meropol NJ, Novotny WF, Lieberman G, Griffing S, Bergsland E. Kabbinavar F, et al. J Clin Oncol. 2003 Jan 1;21(1):60-5. doi: 10.1200/JCO.2003.10.066. J Clin Oncol. 2003. PMID: 12506171 Clinical Trial.

3

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F. Hurwitz H, et al. N Engl J Med. 2004 Jun 3;350(23):2335-42. doi: 10.1056/NEJMoa032691. N Engl J Med. 2004. PMID: 15175435 Free article. Clinical Trial.

4

Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer.

Kabbinavar FF, Hambleton J, Mass RD, Hurwitz HI, Bergsland E, Sarkar S. Kabbinavar FF, et al. J Clin Oncol. 2005 Jun 1;23(16):3706-12. doi: 10.1200/JCO.2005.00.232. Epub 2005 May 2. J Clin Oncol. 2005. PMID: 15867200 Clinical Trial.

5

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.

Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F. Hurwitz HI, et al. J Clin Oncol. 2005 May 20;23(15):3502-8. doi: 10.1200/JCO.2005.10.017. J Clin Oncol. 2005. PMID: 15908660 Clinical Trial.

6

Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab.

Ince WL, Jubb AM, Holden SN, Holmgren EB, Tobin P, Sridhar M, Hurwitz HI, Kabbinavar F, Novotny WF, Hillan KJ, Koeppen H. Ince WL, et al. Among authors: hurwitz hi. J Natl Cancer Inst. 2005 Jul 6;97(13):981-9. doi: 10.1093/jnci/dji174. J Natl Cancer Inst. 2005. PMID: 15998951

7

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.

Scappaticci FA, Fehrenbacher L, Cartwright T, Hainsworth JD, Heim W, Berlin J, Kabbinavar F, Novotny W, Sarkar S, Hurwitz H. Scappaticci FA, et al. Among authors: hurwitz h. J Surg Oncol. 2005 Sep 1;91(3):173-80. doi: 10.1002/jso.20301. J Surg Oncol. 2005. PMID: 16118771

8

Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer.

Hurwitz H, Kabbinavar F. Hurwitz H, et al. Oncology. 2005;69 Suppl 3:17-24. doi: 10.1159/000088480. Epub 2005 Nov 21. Oncology. 2005. PMID: 16301832 Review.

9

Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer.

Jubb AM, Hurwitz HI, Bai W, Holmgren EB, Tobin P, Guerrero AS, Kabbinavar F, Holden SN, Novotny WF, Frantz GD, Hillan KJ, Koeppen H. Jubb AM, et al. Among authors: hurwitz hi. J Clin Oncol. 2006 Jan 10;24(2):217-27. doi: 10.1200/JCO.2005.01.5388. Epub 2005 Dec 19. J Clin Oncol. 2006. PMID: 16365183 Clinical Trial.

10

Angiogenesis inhibition in the treatment of colorectal cancer Part 3 of a 3-part series: targeting VEGF--current and future research directions.

Goldberg RM, Hurwitz HI, Fuchs CS. Goldberg RM, et al. Clin Adv Hematol Oncol. 2005 Dec;3(12):1-10; quiz 11. Clin Adv Hematol Oncol. 2005. PMID: 16555433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

271 results

Search Page